BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17851865)

  • 1. Consequences of inadvertent radioiodine treatment of Graves' disease and thyroid cancer in undiagnosed pregnancy. Can we rely on routine pregnancy testing?
    Berg G; Jacobsson L; Nyström E; Gleisner KS; Tennvall J
    Acta Oncol; 2008; 47(1):145-9. PubMed ID: 17851865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioiodine therapy for women with Graves' disease and the risk of foetal hypothyroidism if they are later found to be pregnant].
    Prinsen AK; Jansen J; Bakker WH; Wildschut HI
    Ned Tijdschr Geneeskd; 2006 Dec; 150(52):2845-8. PubMed ID: 17319213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.
    Traino AC; Di Martino F; Grosso M; Monzani F; Dardano A; Caraccio N; Mariani G; Lazzeri M
    Phys Med Biol; 2005 May; 50(9):2181-91. PubMed ID: 15843745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioactive iodine therapy in Graves' hyperthyroidism.
    Sankar R; Sripathy G
    Natl Med J India; 2000; 13(5):246-51. PubMed ID: 11190053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radioiodine therapy for women with Graves' disease and the risk of foetal hypothyroidism if they are later found to be pregnant].
    Sliedrecht W
    Ned Tijdschr Geneeskd; 2007 Feb; 151(8):503; author reply 503-4. PubMed ID: 17387758
    [No Abstract]   [Full Text] [Related]  

  • 6. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
    Kobe C; Eschner W; Sudbrock F; Weber I; Marx K; Dietlein M; Schicha H
    Nuklearmedizin; 2008; 47(1):13-7. PubMed ID: 18278207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodine treatment of hyperthyroidism in a pregnant women.
    Berg GE; Nyström EH; Jacobsson L; Lindberg S; Lindstedt RG; Mattsson S; Niklasson CA; Norén AH; Westphal OG
    J Nucl Med; 1998 Feb; 39(2):357-61. PubMed ID: 9476950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine therapy during an unknown remained pregnancy and radiation exposure of the fetus. A case report.
    Arndt D; Mehnert WH; Franke WG; Woller P; Laude G; Rockel A; Waller M
    Strahlenther Onkol; 1994 Jul; 170(7):408-14. PubMed ID: 8052940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid remnant radioiodine ablation in a case of concurrent thyroid carcinoma, Graves' disease, and thyroid ophthalmopathy.
    Mansberg R
    Clin Nucl Med; 2007 Jul; 32(7):513-5. PubMed ID: 17581332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possible sequelae of the action of radioactive iodine in man].
    Il'in LA; Arkhangel'skaia GV
    Med Radiol (Mosk); 1973 Aug; 18(8):66-80. PubMed ID: 4801844
    [No Abstract]   [Full Text] [Related]  

  • 11. Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models.
    Walter MA; Schindler C; Christ-Crain M; Müller-Brand J; Müller B
    Eur J Clin Invest; 2009 Jan; 39(1):51-7. PubMed ID: 19087129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scarred atrophic thyroid after I-131 therapy for Graves' disease documented at autopsy.
    Shih WJ; Mitchell B; Schott JC
    J Natl Med Assoc; 2002 Oct; 94(10):915-9. PubMed ID: 12408698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of I-131 therapy on gonads and pregnancy outcome in patients with thyroid cancer.
    Sioka C; Fotopoulos A
    Fertil Steril; 2011 Apr; 95(5):1552-9. PubMed ID: 21300333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A possible method using baseline hormonal levels to prescribe the appropriate oral therapeutic radioiodine dosage for Graves' disease.
    Nakajo M; Tsuchimochi S; Jinguji M; Tanabe H; Umanodan T; Nakabeppu Y
    Ann Nucl Med; 2007 Oct; 21(8):471-6. PubMed ID: 17952556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation doses to patient's relatives following radioiodine therapy.
    Sulaiman BT; Clarke SE
    Med J Malaysia; 1996 Mar; 51(1):131-3. PubMed ID: 10967992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
    El Refaei SM; Shawkat W
    Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airway complication occurring during radioiodine treatment for Graves' disease.
    Kinuya S; Yoneyama T; Michigishi T
    Ann Nucl Med; 2007 Aug; 21(6):367-9. PubMed ID: 17705018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stunning in radioiodine therapy of benign thyroid disease. Quantification and therapeutic relevance].
    Krohn T; Meyer PT; Ocklenburg C; Knollmann D; Nowak B; Schaefer WM
    Nuklearmedizin; 2008; 47(6):248-54. PubMed ID: 19057798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Graves' disease following radioiodine treatment for autonomously functioning thyroid adenoma: case report.
    Martinko J; Cigrovski-Berković M; Becejac B; Solter D; Solter M
    Acta Clin Croat; 2011 Dec; 50(4):615-7. PubMed ID: 22649896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy outcome after 131I therapy.
    Sioka C; Fotopoulos A
    J Nucl Med; 2009 Feb; 50(2):327; author reply 327-8. PubMed ID: 19164224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.